Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic syndrome. - Bazinet A; Montalban-Bravo G; Bataller A; Hammond D; Loghavi S; Chien K; Sasaki K; Bouligny I; Swaminathan M; Jen WY; Popat U; Kadia T; et al. (Leukemia, 2025)